Skip to main content

Advertisement

Log in

Prosthesis-Patient Mismatch After Aortic Valve Replacement

  • Valvular Heart Disease (J Passeri, Section Editor)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Prosthesis-patient mismatch (PPM) occurs when the effective orifice area (EOA) of a normally functioning prosthesis is too small in relation to the patient’s body size, resulting in abnormally high postoperative gradients. PPM is frequent following aortic valve replacement (AVR), and it is associated with increased risk of morbidity and mortality proportionally to its severity. Differential diagnosis between PPM and prosthetic valve stenosis is made by comparing the measured valve effective orifice area, by assessing the changes in valve area and gradient during follow-up and by evaluating leaflet morphology and mobility. Preventive strategies to avoid or minimize PPM should be implemented especially in the patients who are at high risk for severe PPM and in those who have vulnerability factors to PPM. Transcatheter AVR may be superior to surgical AVR for the prevention of PPM and associated adverse cardiac events, particularly in the subset of patients with a small (<21 mm) aortic annulus. In this article, we discuss the most updated data regarding the diagnosis, clinical impact, and prevention of PPM after AVR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Lindman BR, Clavel MA, Mathieu P, et al. Calcific aortic stenosis. Nat Rev. 2016;2:1–28.

    Google Scholar 

  2. Fanning JP, Platts DG, Walters DL, Fraser JF. Transcatheter aortic valve implantation (TAVI): valve design and evolution. Int J Cardiol. 2013;168:1822–31.

    Article  PubMed  Google Scholar 

  3. Dumesnil JG, Yoganathan AP. Theoretical and practical differences between the Gorlin formula and the continuity equation for calculating aortic and mitral valve areas. Am J Cardiol. 1991;67:1268–72.

  4. Dumesnil JG, Yoganathan AP. Valve prosthesis hemodynamics and the problem of high transprosthetic pressure gradients. Eur J Cardio-thorac Surg. 1992;6:S34–8.

    Article  Google Scholar 

  5. Rahimtoola SH. The problem of valve prosthesis-patient mismatch. Circulation. 1978;58:20–4.

    Article  CAS  PubMed  Google Scholar 

  6. Dumesnil JG, Honos GN, Lemieux M, Beauchemin J. Validation and applications of indexed aortic prosthetic valve areas calculated by Doppler echocardiography. J Am Coll Cardiol. 1990;16:637–43.

    Article  CAS  PubMed  Google Scholar 

  7. Blais C, Pibarot P, Garcia D, Chen D, Durand LG, Dumesnil JG. The valve resistance is much more flow dependant than the valve effective orifice area. 49th Annual Meeting - American College of Cardiology. J Am Coll Cardiol. 2000;35:535A.

    Article  Google Scholar 

  8. Pibarot P, Dumesnil JG. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart. 2006;92:1022–9.

    Article  CAS  PubMed  Google Scholar 

  9. Pibarot P, Dumesnil JG, Jobin J, Cartier P, Honos G, Durand LG. Hemodynamic and physical performance during maximal exercise in patients with an aortic bioprosthetic valve. Comparison of stentless versus stented bioprostheses. J Am Coll Cardiol. 1999;34:1609–17.

  10. Pibarot P, Dumesnil JG, Lemieux M, Cartier P, Metras J, Durand LG. Impact of prosthesis-patient mismatch on hemodynamic and symptomatic status, morbidity and mortality after aortic valve replacement with a bioprosthetic heart valve. J Heart Valve Dis. 1998;7:211–8.

    CAS  PubMed  Google Scholar 

  11. Pibarot P, Honos GN, Durand LG, Dumesnil JG. The effect of prosthesis-patient mismatch on aortic bioprosthetic valve hemodynamic performance and patient clinical status. Can J Cardiol. 1996;12:379–87.

    CAS  PubMed  Google Scholar 

  12. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur J Cardiothorac Surg. 2012;42:S45–60. Important document that provides definition of prosthesis-patient mismatch with adjustment for obese patients.

    Article  PubMed  Google Scholar 

  13. Lancellotti P, Pibarot P, Chambers J et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Interamerican Society of Echocardiography and the Brazilian Department of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17:589–90.These are the most recent and complete recommendations for the assessment of prosthetic valve function.

  14. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. 2009;119:1034–48.

    Article  PubMed  Google Scholar 

  15. Pibarot P, Clavel MA, Dahou A. Patient and procedure selection for the prevention of prosthesis-patient mismatch following aortic valve replacement. EuroIntervention. 2015;11(Suppl W):W106–9.

    Article  PubMed  Google Scholar 

  16. Dayan V, Vignolo G, Soca G, Paganini JJ, Brusich D, Pibarot P. Predictors and outcomes of prosthesis patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging. 2016;9:924–33. A recent meta-analysis of the impact on outcomes and predictors of prosthesis-patient mismatch.

  17. Pibarot P, Dumesnil JG. Valve prosthesis-patient mismatch, 1978 to 2011: from original concept to compelling evidence. J Am Coll Cardiol. 2012;60:1136–9.

    Article  PubMed  Google Scholar 

  18. Clavel MA, Webb JG, Rodés-Cabau J, et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation. 2010;122:1928–36.

    Article  CAS  PubMed  Google Scholar 

  19. Jilaihawi H, Chin D, Spyt T, et al. Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic-Corevalve bioprosthesis. Eur Heart J. 2010;31:857–64.

    Article  PubMed  Google Scholar 

  20. Kalavrouziotis D, Rodés-Cabau J, Bagur R, et al. Transcatheter aortic valve implantation in patients with severe aortic stenosis and small aortic annulus. J Am Coll Cardiol. 2011;58:1016–24.

    Article  PubMed  Google Scholar 

  21. Kukucka M, Pasic M, Dreysse S, et al. Patient-prosthesis mismatch after transapical aortic valve implantation: incidence and impact on survival. J Thorac Cardiovasc Surg. 2013;145:391–7.

    Article  PubMed  Google Scholar 

  22. Tzikas A, Piazza N, Geleijnse ML, et al. Prosthesis-patient mismatch after transcatheter aortic valve implantation with the medtronic CoreValve system in patients with aortic stenosis. Am J Cardiol. 2010;106:255–60.

    Article  PubMed  Google Scholar 

  23. Nombela-Franco L, Ruel M, Radhakrishnan S, et al. Comparison of hemodynamic performance of self-expandable corevalve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Am J Cardiol. 2013;111:1026–33.

    Article  PubMed  Google Scholar 

  24. Zorn 3rd GL, Little SH, Tadros P, et al. Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis. J Thorac Cardiovasc Surg. 2016;151:1014–23. e3.

    Article  PubMed  Google Scholar 

  25. Clavel MA, Webb JG, Pibarot P, et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol. 2009;53:1883–91.

    Article  PubMed  Google Scholar 

  26. Pibarot P, Weissman NJ, Stewart WJ, et al. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis- A PARTNER trial cohort A analysis. J Am Coll Cardiol. 2014;64:1323–34. This study reports the impact on outcomes of prosthesis-patient mismatch after transcatheter aortic valve replacement in the context of the PARTNER-I trial.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Lévy F, Donal E, Biere L, et al. Hemodynamic performance during exercise of the new St. Jude Trifecta aortic bioprosthesis: results from a French multicenter study. J Am Soc Echocardiogr. 2014;27:590–7.

    Article  PubMed  Google Scholar 

  28. Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. 2009;54:2251–60.

    Article  PubMed  Google Scholar 

  29. Chambers J, Rimington H, Rajani R, Hodson F, Blauth C. Hemodynamic performance on exercise: comparison of a stentless and stented biological aortic valve replacement. J Heart Valve Dis. 2004;13:729–33.

    PubMed  Google Scholar 

  30. Fries R, Wendler O, Schieffer H, Schäfers H-J. Comparative rest and exercise hemodynamics of 23-mm stentless versus 23-mm stented aortic bioprostheses. Ann Thorac Surg. 2000;69:817–22.

    Article  CAS  PubMed  Google Scholar 

  31. Pibarot P, Dumesnil JG, Jobin J, Lemieux M, Honos G, Durand LG. Usefulness of the indexed effective orifice area at rest in predicting an increase in gradient during maximum exercise in patients with a bioprosthesis in the aortic valve position. Am J Cardiol. 1999;83:542–6.

    Article  CAS  PubMed  Google Scholar 

  32. Eriksson MJ, Brodin LA, Dellgren GN, Radegran K. Rest and exercise hemodynamics of an extended stentless aortic bioprosthesis. J Heart Valve Dis. 1997;6:653–60.

    CAS  PubMed  Google Scholar 

  33. Jaffe WM, Coverdale HA, Roche AHG, Whitlock RML, Neutze JM, Barratt-Boyes BG. Rest and exercise hemodynamics of 20 to 23 mm allograft, Medtronic Intact (porcine), and St. Jude medical valves in the aortic position. J Thorac Cardiovasc Surg. 1990;100:167–74.

    CAS  PubMed  Google Scholar 

  34. Rodés-Cabau J, Pibarot P, Suri RM, et al. Impact of aortic annulus size on valve hemodynamics and clinical outcomes after transcatheter and surgical aortic valve replacement: insights from the PARTNER Trial. Circ Cardiovasc Interv. 2014;7:701–11.

    Article  PubMed  Google Scholar 

  35. Angeloni E, Melina G, Pibarot P, et al. Impact of prosthesis-patient mismatch on the regression of secondary mitral regurgitation after isolated aortic valve replacement with a bioprosthetic valve in patients with severe aortic stenosis. Circ Cardiovasc Imaging. 2012;5:36–42.

    Article  PubMed  Google Scholar 

  36. Blais C, Dumesnil JG, Baillot R, Simard S, Doyle D, Pibarot P. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation. 2003;108:983–8.

    Article  PubMed  Google Scholar 

  37. Bleiziffer S, Ali A, Hettich IM, et al. Impact of the indexed effective orifice area on mid-term cardiac-related mortality after aortic valve replacement. Heart. 2010;96:865–71.

    Article  PubMed  Google Scholar 

  38. Kohsaka S, Mohan S, Virani S, et al. Prosthesis-patient mismatch affects long-term survival after mechanical valve replacement. J Thorac Cardiovasc Surg. 2008;135:1076–80.

    Article  PubMed  Google Scholar 

  39. Mohty D, Dumesnil JG, Echahidi N, et al. Impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: influence of age, obesity, and left ventricular dysfunction. J Am Coll Cardiol. 2009;53:39–47.

    Article  PubMed  Google Scholar 

  40. Mohty D, Malouf JF, Girard SE, et al. Impact of prosthesis-patient mismatch on long-term survival in patients with small St. Jude medical mechanical prostheses in the aortic position. Circulation. 2006;113:420–6.

    Article  PubMed  Google Scholar 

  41. Ruel M, Rubens FD, Masters RG, et al. Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves. J Thorac Cardiovasc Surg. 2004;127:149–59.

    Article  PubMed  Google Scholar 

  42. Tasca G, Brunelli F, Cirillo M, et al. Impact of valve prosthesis-patient mismatch on left ventricular mass regression following aortic valve replacement. Ann Thorac Surg. 2005;79:505–10.

    Article  PubMed  Google Scholar 

  43. Tasca G, Mhagna Z, Perotti S, et al. Impact of prosthesis-patient mismatch on cardiac events and midterm mortality after aortic valve replacement in patients with pure aortic stenosis. Circulation. 2006;113:570–6.

    Article  PubMed  Google Scholar 

  44. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349:343–9.

    Article  PubMed  Google Scholar 

  45. Walther T, Rastan A, Falk V, et al. Patient prosthesis mismatch affects short- and long-term outcomes after aortic valve replacement. Eur J Cardiothorac Surg. 2006;30:15–9.

    Article  PubMed  Google Scholar 

  46. Tasca G, Brunelli F, Cirillo M, et al. Impact of the improvement of valve area achieved with aortic valve replacement on the regression of left ventricular hypertrophy in patients with pure aortic stenosis. Ann Thorac Surg. 2005;79:1291–6.

    Article  PubMed  Google Scholar 

  47. Bakhtiary F, Schiemann M, Dzemali O, et al. Impact of patient-prosthesis mismatch and aortic valve design on coronary flow reserve after aortic valve replacement. J Am Coll Cardiol. 2007;49:790–6.

    Article  PubMed  Google Scholar 

  48. Petit-Eisenmann H, Epailly E, Velten M et al. Impact of prosthesis-patient mismatch on long-term functional capacity after mechanical aortic valve replacement. Can J Cardiol 2016.

  49. Van Slooten YJ, van Melle JP, Freling HG, et al. Aortic valve prosthesis-patient mismatch and exercise capacity in adult patients with congenital heart disease. Heart. 2016;102:107–13.

    Article  PubMed  Google Scholar 

  50. Flameng W, Herregods MC, Vercalsteren M, Herijgers P, Bogaerts K, Meuris B. Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves. Circulation. 2010;121:2123–9.

    Article  PubMed  Google Scholar 

  51. Urso S, Calderon P, Sadaba R, et al. Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration. J Card Surg. 2014;29:439–44.

    Article  PubMed  Google Scholar 

  52. Mahjoub H, Mathieu P, Larose É, et al. Determinants of aortic bioprosthetic valve calcification assessed by multidetector CT. Heart. 2015;101:472–7.

    Article  PubMed  Google Scholar 

  53. Johnston DR, Soltesz EG, Vakil N, et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015;99:1239–47.

    Article  PubMed  Google Scholar 

  54. Girerd N, Mathieu P, Dumesnil JG, et al. Impact of aortic stenosis severity and its interaction with prosthesis-patient mismatch on operative mortality following aortic valve replacement. J Heart Valve Dis. 2012;21:158–67.

    PubMed  Google Scholar 

  55. Ruel M, Al-Faleh H, Kulik A, Chan K, Mesana TG, Burwash IG. Prosthesis-patient mismatch after aortic valve replacement predominantly affects patients with pre-existing left ventricular dysfunction: effect on survival, freedom from heart failure, and left ventricular mass regression. J Thorac Cardiovasc Surg. 2006;131:1036–44.

    Article  PubMed  Google Scholar 

  56. Kulik A, Burwash IG, Kapila V, Mesana TG, Ruel M. Long-term outcomes after valve replacement for low-gradient aortic stenosis: impact of prosthesis-patient mismatch. Circulation. 2006;114:I5553–8.

    Google Scholar 

  57. Unger P, Magne J, Vanden Eynden F, et al. Impact of prosthesis-patient mismatch on mitral regurgitation after aortic valve replacement. Heart. 2010;96:1627–32.

    Article  CAS  PubMed  Google Scholar 

  58. Urso S, Sadaba R, Aldamiz-Echevarria G. Is patient-prosthesis mismatch an independent risk factor for early and mid-term overall mortality in adult patients undergoing aortic valve replacement? Interact Cardiovasc Thorac Surg. 2009;9:510–8.

    Article  PubMed  Google Scholar 

  59. Urso S, Sadaba R, Vives M, et al. Patient-prosthesis mismatch in elderly patients undergoing aortic valve replacement: impact on quality of life and survival. J Heart Valve Dis. 2009;18:248–55.

    PubMed  Google Scholar 

  60. Mohty D, Boulogne C, Magne J, et al. Prevalence and long-term outcome of aortic prosthesis-patient mismatch in patients with paradoxical low-flow severe aortic stenosis. Circulation. 2014;130:S25–31.

    Article  PubMed  Google Scholar 

  61. Head S, Mokhles M, Osnabrugge R, et al. The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27,186 patients with 133,141 patient-years. Eur Heart J. 2012;33:1518–29. First meta-analysis on the impact of prosthesis-patient mismatch on mortality.

    Article  PubMed  Google Scholar 

  62. Ewe SH, Muratori M, Delgado V, et al. Hemodynamic and clinical impact of prosthesis-patient mismatch after transcatheter aortic valve implantation. J Am Coll Cardiol. 2011;58:1910–8.

    Article  PubMed  Google Scholar 

  63. Zoghbi WA, Chambers JB, Dumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2009;22:975–1014. Recommendation of the American Society of Echocardiography for the Doppler-echocardiographic assessment of prosthetic valves.

    Article  PubMed  Google Scholar 

  64. Bach DS. Echo/doppler evaluation of hemodynamics after aortic valve replacement: principles of interrogation and evaluation of high gradients. J Am Coll Cardiol Img. 2010;3:296–304.

    Article  Google Scholar 

  65. Dumesnil JG, Pibarot P. Prosthesis-patient mismatch: an update. Curr Cardiol Rep. 2011;13:250–7.

    Article  PubMed  Google Scholar 

  66. Pibarot P, Dumesnil JG. Doppler echocardiographic evaluation of prosthetic valve function. Heart. 2012;98:69–78.

    Article  PubMed  Google Scholar 

  67. Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373:2015–24.

    Article  CAS  PubMed  Google Scholar 

  68. Ben Zekry S, Saad RM, Ozkan M, et al. Flow acceleration time and ratio of acceleration time to ejection time for prosthetic aortic valve function. JACC Cardiovasc Imaging. 2011;4:1161–70.

    Article  PubMed  Google Scholar 

  69. Clavel MA, Rodés-Cabau J, Dumont É, et al. Validation and characterization of transcatheter aortic valve effective orifice area measured by doppler echocardiography. J Am Coll Cardiol Img. 2011;4:1053–62.

    Article  Google Scholar 

  70. Bloomfield GS, Gillam LD, Hahn RT, et al. A practical guide to multimodality imaging of transcatheter aortic valve replacement. JACC Cardiovasc Imaging. 2012;5:441–55.

    Article  PubMed  Google Scholar 

  71. Shames S, Koczo A, Hahn R, Jin Z, Picard MH, Gillam LD. Flow characteristics of the SAPIEN aortic valve: the importance of recognizing in-stent flow acceleration for the echocardiographic assessment of valve function. J Am Soc Echocardiogr. 2012;25:603–9.

    Article  PubMed  Google Scholar 

  72. Zamorano JL, Badano LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J. 2011;32:2189–214.

    Article  PubMed  Google Scholar 

  73. del Trigo M, Munoz-Garcia AJ, Wijeysundera HC, et al. Incidence, timing and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol. 2016;67:644–55.

    Article  PubMed  Google Scholar 

  74. Latib A, Naganuma T, Abdel-Wahab M, et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv. 2015;8:1–8.

    Article  Google Scholar 

  75. Seiffert M, Conradi L, Baldus S, et al. Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses. J Thorac Cardiovasc Surg. 2012;143:617–24.

    Article  PubMed  Google Scholar 

  76. Dvir D, Barbanti M, Tan J, Webb JG. Transcatheter aortic valve-in-valve implantation for patients with degenerative surgical bioprosthetic valves. Curr Probl Cardiol. 2014;39:7–27.

    Article  PubMed  Google Scholar 

  77. Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312:162–70.

    Article  CAS  PubMed  Google Scholar 

  78. Yadlapati A, Diep J, Barnes M, Grogan T, Bethencourt DM, Vorobiof G. Comprehensive hemodynamic comparison and frequency of patient-prosthesis mismatch between the St. Jude Medical trifecta and epic bioprosthetic aortic valves. J Am Soc Echocardiogr. 2014;27:581–9.

    Article  PubMed  Google Scholar 

  79. Amat-Santos IJ, Dahou A, Webb J, et al. Comparison of hemodynamic performance of the balloon-expandable SAPIEN 3 versus SAPIEN XT transcatheter valve. Am J Cardiol. 2014;114:1075c82.

  80. Kodali S, Thourani VH, White J et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J. 2016;37:2252–62.

  81. Thourani VH, Kodali S, Makkar RR et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 2016;387:2218–25.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philippe Pibarot DVM, PhD.

Ethics declarations

Conflict of Interest

Abdellaziz Dahou and Haïfa Mahjoub each declare no potential conflicts of interest.

Philippe Pibarot reports grants from Edwards Lifesciences, Cardiac Phoenix, and V-Wave Ltd.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Valvular Heart Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dahou, A., Mahjoub, H. & Pibarot, P. Prosthesis-Patient Mismatch After Aortic Valve Replacement. Curr Treat Options Cardio Med 18, 67 (2016). https://doi.org/10.1007/s11936-016-0488-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11936-016-0488-0

Keywords

Navigation